Should CAR-T therapy be considered for a kidney transplant patient with refractory PTLD?

There are only sparse case reports of CD-19-directed CAR T cells being used to treat PTLD following solid organ transplants. Thus, no evidence-based guidelines exist for the management of immunosuppressive medications to prevent graft failure in this setting and the rate and severity of common post-...